Page last updated: 2024-10-18

gamma-butyrobetaine and Acute Coronary Syndrome

gamma-butyrobetaine has been researched along with Acute Coronary Syndrome in 1 studies

4-(trimethylammonio)butanoate : An amino-acid betaine gamma-aminobutyric acid zwitterion in which all of the hydrogens attached to the nitrogen are replaced by methyl groups.

Acute Coronary Syndrome: An episode of MYOCARDIAL ISCHEMIA that generally lasts longer than a transient anginal episode that ultimately may lead to MYOCARDIAL INFARCTION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Davies, A1
Wenzl, FA1
Li, XS1
Winzap, P1
Obeid, S1
Klingenberg, R1
Mach, F1
Räber, L1
Muller, O1
Matter, CM1
Laaksonen, R1
Wang, Z1
Hazen, SL1
Lüscher, TF1

Other Studies

1 other study available for gamma-butyrobetaine and Acute Coronary Syndrome

ArticleYear
Short and medium chain acylcarnitines as markers of outcome in diabetic and non-diabetic subjects with acute coronary syndromes.
    International journal of cardiology, 2023, 10-15, Volume: 389

    Topics: Acetylcarnitine; Acute Coronary Syndrome; Carnitine; Clinical Studies as Topic; Cohort Studies; Diab

2023